Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 109

1.

Thyroid hormone actions in liver cancer.

Wu SM, Cheng WL, Lin CD, Lin KH.

Cell Mol Life Sci. 2013 Jun;70(11):1915-36. doi: 10.1007/s00018-012-1146-7. Epub 2012 Sep 6. Review.

PMID:
22955376
2.

Negative modulation of the epigenetic regulator, UHRF1, by thyroid hormone receptors suppresses liver cancer cell growth.

Wu SM, Cheng WL, Liao CJ, Chi HC, Lin YH, Tseng YH, Tsai CY, Chen CY, Lin SL, Chen WJ, Yeh YH, Huang CY, Chen MH, Yeh YC, Lin KH.

Int J Cancer. 2015 Jul 1;137(1):37-49. doi: 10.1002/ijc.29368. Epub 2014 Dec 10.

3.

Identification of naturally occurring dominant negative mutants of thyroid hormone alpha 1 and beta 1 receptors in a human hepatocellular carcinoma cell line.

Lin KH, Zhu XG, Shieh HY, Hsu HC, Chen ST, McPhie P, Cheng SY.

Endocrinology. 1996 Oct;137(10):4073-81.

PMID:
8828459
4.

Thyroid hormone receptors mutated in liver cancer function as distorted antimorphs.

Chan IH, Privalsky ML.

Oncogene. 2006 Jun 15;25(25):3576-88. Epub 2006 Jan 23.

5.

Positive regulation of spondin 2 by thyroid hormone is associated with cell migration and invasion.

Liao CH, Yeh SC, Huang YH, Chen RN, Tsai MM, Chen WJ, Chi HC, Tai PJ, Liao CJ, Wu SM, Cheng WL, Pai LM, Lin KH.

Endocr Relat Cancer. 2010 Jan 29;17(1):99-111. doi: 10.1677/ERC-09-0050. Print 2010 Mar.

6.

Thyroid hormone receptors suppress pituitary tumor transforming gene 1 activity in hepatoma.

Chen RN, Huang YH, Yeh CT, Liao CH, Lin KH.

Cancer Res. 2008 Mar 15;68(6):1697-706. doi: 10.1158/0008-5472.CAN-07-5492.

7.

The gene regulating activity of thyroid hormone nuclear receptors is modulated by cell-type specific factors.

Lin K, Chen Sl, Zhu XG, Shieh H, McPhie P, Cheng S.

Biochem Biophys Res Commun. 1997 Sep 18;238(2):280-4.

PMID:
9299494
8.

Modulation of thyroid hormone action by mutant thyroid hormone receptors, c-erbA alpha 2 and peroxisome proliferator-activated receptor: evidence for different mechanisms of inhibition.

Meier-Heusler SC, Zhu X, Juge-Aubry C, Pernin A, Burger AG, Cheng SY, Meier CA.

Mol Cell Endocrinol. 1995 Jan;107(1):55-66.

PMID:
7796935
9.

Mechanism of thyroid hormone action.

Harvey CB, Williams GR.

Thyroid. 2002 Jun;12(6):441-6. Review.

PMID:
12165104
12.

Thyroid hormone receptor inhibits hepatoma cell migration through transcriptional activation of Dickkopf 4.

Chi HC, Liao CH, Huang YH, Wu SM, Tsai CY, Liao CJ, Tseng YH, Lin YH, Chen CY, Chung IH, Wu TI, Chen WJ, Lin KH.

Biochem Biophys Res Commun. 2013 Sep 13;439(1):60-5. doi: 10.1016/j.bbrc.2013.08.028. Epub 2013 Aug 16.

PMID:
23958302
13.

Activation of myoD gene transcription by 3,5,3'-triiodo-L-thyronine: a direct role for the thyroid hormone and retinoid X receptors.

Muscat GE, Mynett-Johnson L, Dowhan D, Downes M, Griggs R.

Nucleic Acids Res. 1994 Feb 25;22(4):583-91.

14.

Tumor suppressor p53 is a negative regulator in thyroid hormone receptor signaling pathways.

Bhat MK, Yu Cl, Yap N, Zhan Q, Hayashi Y, Seth P, Cheng S.

J Biol Chem. 1997 Nov 14;272(46):28989-93.

15.
16.
17.

Thyroid hormone enhanced human hepatoma cell motility involves brain-specific serine protease 4 activation via ERK signaling.

Chen CY, Chung IH, Tsai MM, Tseng YH, Chi HC, Tsai CY, Lin YH, Wang YC, Chen CP, Wu TI, Yeh CT, Tai DI, Lin KH.

Mol Cancer. 2014 Jul 1;13:162. doi: 10.1186/1476-4598-13-162.

18.
20.

Dominant negative activity of mutant thyroid hormone alpha1 receptors from patients with hepatocellular carcinoma.

Lin KH, Zhu XG, Hsu HC, Chen SL, Shieh HY, Chen ST, McPhie P, Cheng SY.

Endocrinology. 1997 Dec;138(12):5308-15.

PMID:
9389515

Supplemental Content

Support Center